2-Chloro-1-(chloromethyl)-3-nitrobenzene

Catalog No.: 
ACLFIG395
CAS No.: 
108772-93-6
Molecular Formula: 
C7H5Cl2NO2
Molecular Weight: 
206.03
2-Chloro-1-(chloromethyl)-3-nitrobenzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$219.00InquiryInquiry
100mg97%$318.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-1-(chloromethyl)-3-nitrobenzene
IUPAC Name2-chloro-1-(chloromethyl)-3-nitrobenzene
Molecular FormulaC7H5Cl2NO2
Molecular Weight206.03
SMILESO=[N+](C1=C(Cl)C(CCl)=CC=C1)[O-]
InChI KeyZQJZFYFOZXMOCZ-UHFFFAOYSA-N
Synonym2-chloro-1-(chloromethyl)-3-nitrobenzene;Benzene, 2-chloro-1-(chloromethyl)-3-nitro-
CAS No.108772-93-6

Safety Data

Pictogram
Corrosive
Signal Word
Danger
Hazard Statement(s)
H290-H314
Precautionary Statement(s)
P234-P260-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340+P310-P305+P351+P338+P310-P363-P390-P405-P406-P501

Synthetic Route by SureRoute

1. ACLFIG395 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLGSU492 route compound structure diagram
    ACLGSU49289639-98-5In Stock
  4. Then
  5. ACLFIG395 route product structure diagram
    ACLFIG395108772-93-6
Inquiry

2. ACLFIG395 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFHPO905 route compound structure diagram
    ACFHPO90589642-16-0In Stock
  4. Then
  5. ACLFIG395 route product structure diagram
    ACLFIG395108772-93-6
Inquiry

3. ACLFIG395 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLFIG395 route product structure diagram
    ACLFIG395108772-93-6
Inquiry

Comments (0)